Biostar Pharmaceuticals, Inc. (BSPM) Touches $1.77 Formed H&S; Eii Capital Management Has Lowered Brandywine Rlty Tr (BDN) Position

Eii Capital Management Inc decreased Brandywine Rlty Tr (BDN) stake by 70.15% reported in 2017Q3 SEC filing. Eii Capital Management Inc sold 193,624 shares as Brandywine Rlty Tr (BDN)’s stock rose 6.44%. The Eii Capital Management Inc holds 82,376 shares with $1.44 million value, down from 276,000 last quarter. Brandywine Rlty Tr now has $3.22B valuation. The stock decreased 0.16% or $0.03 during the last trading session, reaching $18.19. About 1.46 million shares traded or 2.20% up from the average. Brandywine Realty Trust (NYSE:BDN) has risen 17.77% since January 2, 2017 and is uptrending. It has outperformed by 1.07% the S&P500.

Biostar Pharmaceuticals, Inc. (BSPM) formed inverse H&S with $1.84 target or 4.00% above today’s $1.77 share price. Biostar Pharmaceuticals, Inc. (BSPM) has $4.67 million valuation. The stock decreased 2.71% or $0.05 during the last trading session, reaching $1.77. About 21,471 shares traded. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has risen 57.27% since January 2, 2017 and is uptrending. It has outperformed by 40.57% the S&P500.

Eii Capital Management Inc increased Amag Pharmaceuticals Inc Com (NASDAQ:AMAG) stake by 35,090 shares to 119,690 valued at $2.21M in 2017Q3. It also upped Simon Ppty Group Inc New Com (NYSE:SPG) stake by 21,951 shares and now owns 65,512 shares. Digital Realty Trust Inc (NYSE:DLR) was raised too.

Among 13 analysts covering Brandywine Realty Trust (NYSE:BDN), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Brandywine Realty Trust had 31 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Monday, October 23. The stock of Brandywine Realty Trust (NYSE:BDN) has “Outperform” rating given on Monday, January 9 by Raymond James. KeyBanc Capital Markets upgraded the shares of BDN in report on Tuesday, December 19 to “Buy” rating. As per Wednesday, October 18, the company rating was maintained by SunTrust. On Friday, November 13 the stock rating was initiated by BB&T Capital with “Buy”. The rating was maintained by Mizuho with “Buy” on Thursday, October 19. The rating was upgraded by KeyBanc Capital Markets on Monday, May 15 to “Sector Weight”. The firm earned “Buy” rating on Monday, December 19 by Evercore. Credit Suisse upgraded Brandywine Realty Trust (NYSE:BDN) rating on Monday, October 12. Credit Suisse has “Outperform” rating and $16 target. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, September 18.

Analysts await Brandywine Realty Trust (NYSE:BDN) to report earnings on January, 30. They expect $0.33 EPS, down 5.71% or $0.02 from last year’s $0.35 per share. BDN’s profit will be $58.40 million for 13.78 P/E if the $0.33 EPS becomes a reality. After $0.35 actual EPS reported by Brandywine Realty Trust for the previous quarter, Wall Street now forecasts -5.71% negative EPS growth.

Since August 8, 2017, it had 0 insider buys, and 5 insider sales for $2.39 million activity. Fowler Wyche sold $30,680 worth of stock or 1,824 shares. On Monday, December 18 SWEENEY GERARD H sold $370,185 worth of Brandywine Realty Trust (NYSE:BDN) or 20,000 shares. On Wednesday, October 25 the insider NICHOLS ANTHONY A SR sold $87,045. $1.86 million worth of Brandywine Realty Trust (NYSE:BDN) was sold by REDD WILLIAM D on Thursday, August 10. Shares for $42,250 were sold by WIRTH TOM.